COLAO, ANNAMARIA
 Distribuzione geografica
Continente #
NA - Nord America 15.849
EU - Europa 8.516
AS - Asia 5.093
AF - Africa 346
SA - Sud America 78
Continente sconosciuto - Info sul continente non disponibili 24
OC - Oceania 22
Totale 29.928
Nazione #
US - Stati Uniti d'America 15.503
IT - Italia 2.606
CN - Cina 2.389
SG - Singapore 2.036
SE - Svezia 1.077
NL - Olanda 1.047
IE - Irlanda 901
FI - Finlandia 844
DE - Germania 834
UA - Ucraina 522
CA - Canada 322
VN - Vietnam 318
CI - Costa d'Avorio 315
GB - Regno Unito 269
FR - Francia 141
IN - India 112
TR - Turchia 80
BE - Belgio 44
CZ - Repubblica Ceca 42
ES - Italia 39
IR - Iran 31
RU - Federazione Russa 30
BR - Brasile 29
EU - Europa 24
MX - Messico 22
AU - Australia 19
HK - Hong Kong 19
RO - Romania 19
JP - Giappone 16
CL - Cile 15
PL - Polonia 15
CH - Svizzera 13
IQ - Iraq 13
KR - Corea 13
AR - Argentina 12
CO - Colombia 12
ID - Indonesia 12
AT - Austria 11
EG - Egitto 11
DK - Danimarca 9
HU - Ungheria 8
IL - Israele 7
NG - Nigeria 7
PE - Perù 7
AE - Emirati Arabi Uniti 6
PH - Filippine 6
PT - Portogallo 6
TH - Thailandia 6
TW - Taiwan 6
BG - Bulgaria 5
GR - Grecia 5
HR - Croazia 5
NO - Norvegia 5
MY - Malesia 4
SI - Slovenia 4
SK - Slovacchia (Repubblica Slovacca) 4
ZA - Sudafrica 4
EC - Ecuador 3
LK - Sri Lanka 3
NZ - Nuova Zelanda 3
BF - Burkina Faso 2
ET - Etiopia 2
GE - Georgia 2
KW - Kuwait 2
LB - Libano 2
LI - Liechtenstein 2
LV - Lettonia 2
MC - Monaco 2
NP - Nepal 2
UG - Uganda 2
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BN - Brunei Darussalam 1
DZ - Algeria 1
KH - Cambogia 1
LT - Lituania 1
MA - Marocco 1
MD - Moldavia 1
MM - Myanmar 1
MN - Mongolia 1
MO - Macao, regione amministrativa speciale della Cina 1
PA - Panama 1
PR - Porto Rico 1
PS - Palestinian Territory 1
RS - Serbia 1
SA - Arabia Saudita 1
TN - Tunisia 1
VA - Santa Sede (Città del Vaticano) 1
Totale 29.928
Città #
Chandler 3.177
Singapore 1.449
Millbury 1.324
Amsterdam 1.000
Princeton 911
Jacksonville 844
Nanjing 825
Ashburn 721
Naples 582
Wilmington 495
Napoli 468
Beijing 444
Boston 349
Des Moines 314
Dong Ket 313
Ottawa 270
Santa Clara 224
Nanchang 222
Woodbridge 210
Hebei 171
Lawrence 171
Norwalk 147
Shenyang 139
Jiaxing 119
Ann Arbor 115
Seattle 111
Houston 102
Boardman 101
Tianjin 83
Rome 78
Kronberg 76
Changsha 74
Redwood City 74
Falls Church 72
Kunming 69
Milan 61
Pune 56
Washington 53
Dublin 51
Dearborn 46
Indiana 46
Buffalo 42
Fairfield 42
Munich 39
Brno 37
San Mateo 34
New York 32
Los Angeles 31
Redmond 27
Lappeenranta 23
Paris 22
Hangzhou 21
Lanzhou 21
Shanghai 21
Jinan 20
Ardabil 19
Changchun 19
Montréal 19
Guangzhou 18
Istanbul 18
San Francisco 17
Augusta 16
Tappahannock 16
Courcelles 15
Mcallen 15
Toronto 15
Frankfurt am Main 14
Marigliano 14
Torino 14
Zhengzhou 14
Bologna 13
Duncan 13
Helsinki 13
Hong Kong 13
Ningbo 13
Orange 13
Salerno 13
Altamura 12
Prineville 12
Caserta 10
London 10
Mountain View 10
Philadelphia 10
Sandston 10
Yellow Springs 10
Afragola 9
Cagliari 9
Ledegem 9
Atlanta 8
Bari 8
Elmas 8
Madrid 8
Mumbai 8
Pagani 8
Pittsburgh 8
Portici 8
Siena 8
Casoria 7
Chicago 7
Council Bluffs 7
Totale 17.107
Nome #
Systemic complications of acromegaly: epidemiology, pathogenesis, and management 396
Adenomi Ipofisari 116
Sensori in fibra ottica integrati in aghi impiegati per l'ablazione percutanea, la necrotizzazione e in terapie varie 101
A Community-Based, Technology-Supported Health Service for Detecting and Preventing Frailty among Older Adults: A Participatory Design Development Process 100
Mediterranean diet as medical prescription in menopausal women with obesity: a practical guide for nutritionists 97
Metabolic and anthropometric changes in early breast cancer patients receiving adjuvant therapy 89
Circulating insulin-like growth factor-I levels are correlated with the atherosclerotic profile in healthy subjects independently of age 83
Flavor perception test: evaluation in patients with Kallmann syndrome 76
Very low-calorie ketogenic diet (VLCKD) in patients with psoriasis and obesity: an update for dermatologists and nutritionists 76
Diagnostic issues faced by a rare disease healthcare network during Covid-19 outbreak: data from the Campania Rare Disease Registry 74
Vitamin-D status and mineral metabolism in two ethnic populations with sarcoidosis 71
Growth hormone deficiency is associated with worse cardiac function, physical performance, and outcome in chronic heart failure: Insights from the T.O.S.CA. GHD study 71
Metformin Use Is Associated With Longer Progression-Free Survival of Patients With Diabetes and Pancreatic Neuroendocrine Tumors Receiving Everolimus and/or Somatostatin Analogues 71
Short-term effects of growth hormone (GH) treatment or deprivation on cardiovascular risk parameters and intima-media thickness at carotid arteries in patients with severe GH deficiency 70
Reciprocal interplay between thyroid hormone and microRNA-21 regulates hedgehog pathway-driven skin tumorigenesis 69
Does a gender-related effect of growth hormone (GH) replacement exist on cardiovascular risk factors, cardiac morphology, and performance and atherosclerosis? Results of a two-year open, prospective study in young adult men and women with severe GH deficiency 67
Coffee consumption, health benefits and side effects: a narrative review and update for dietitians and nutritionists 67
Cabergoline plus lanreotide for ectopic Cushing's syndrome. 65
Antipituitary antibodies in idiopathic hyperprolactinemic patients 65
Efficacy and safety of radiofrequency thermal ablation in the treatment of thyroid nodules with pressure symptoms in elderly patients. 64
Role of dehydroepiandrosterone sulfate levels on body composition after laparoscopic adjustable gastric banding in pre-menopausal morbidly obese women. 63
Lack of electrocardiographic changes in women with polycystic ovary syndrome. 62
Potential role of cinacalcet hydrochloride in sporadic primary hyperparathyroidism without surgery indication. 61
Effect of gender and gonadal status on the long-term response to somatostatin analogue treatment in acromegaly 61
Adverse events associated with somatostatin analogs in acromegaly. 60
MEN1 family with a novel frameshift mutation. 60
Effects of sex steroids on bone in women with subclinical or overt endogenous hypercortisolism 60
Neuropsychiatric disorders in Cushing's syndrome. 59
Nutrition: a key environmental dietary factor in clinical severity and cardio-metabolic risk in psoriatic male patients evaluated by 7-day food-frequency questionnaire 59
Predictors of tumor shrinkage after primary therapy with somatostatin analogs in acromegaly: a prospective study in 99 patients 59
Thyroid function and morphology after a successful kidney transplantation. 58
Combined therapy of somatostatin analogues and dopamine agonists in the treatment of pituitary tumours 58
GH INSUFFICIENCY IN OBESE PATIENTS. 58
Efficacy of 12-month treatment with the GH receptor antagonist pegvisomant in patients with acromegaly resistant to long-term, high-dose somatostatin analog treatment: effect on IGF-I levels, tumor mass, hypertension and glucose tolerance 58
Weekly clodronate treatment prevents bone loss and vertebral fractures in womenwith subclinical Cushing's syndrome. 58
The 17β-hydroxysteroid dehydrogenase type 3 deficiency: a case report of an 18-year patient and review of the literature. 58
Atypical pituitary adenomas: clinical characteristics and role of ki-67 and p53 in prognostic and therapeutic evaluation. A series of 50 patients 58
Hepatic arterial embolization in patients with neuroendocrine tumors. 57
CORRELATION BETWEEN SEMINAL CARNITINE AND FUNCTIONAL CHARACTERISTICS IN MEN WITH SEMEN DYSFUNCTION OF VARIOUS ORIGINS. 57
Sulfur amino acids in Cushing's disease: insight in homocysteine and taurine levels in patients with active and cured disease 57
Long period fiber grating nano-optrode for cancer biomarker detection 57
GLP-1: benefits beyond pancreas. 55
First-line therapy of acromegaly: a statement of the A.L.I.C.E. (Acromegaly primary medical treatment Learning and Improvement with Continuous Medical Education) Study Group 55
Bioelectrical phase angle and psoriasis: a novel association with psoriasis severity, quality of life and metabolic syndrome. 55
The evolving field of kinase inhibitors in thyroid cancer. 54
Correlation between Seminal Carnitine and Functional Spermatozoal Characteristics in Men with Semen Dysfunction of Various Origins 54
Pasireotide LAR maintains inhibition of GH and IGF-1 in patients with acromegaly for up to 25 months: results from the blinded extension phase of a randomized, double-blind, multicenter, Phase III study. 53
A 12-month phase 3 study of pasireotide in cushing's disease 53
Homocysteine levels and C677T polymorphism of methylenetetrahydrofolate reductase in women with polycystic ovary syndrome 53
The treatment with growth hormone receptor antagonist in acromegaly: effect on vascular structure and function in patients resistant to somatostatin analogues. 53
Reduced bone mineral density in glycogen storage disease type III: Evidence for a possible connection between metabolic imbalance and bone homeostasis 53
Quercetin and its derivative Q2 modulate chromatin dynamics in adipogenesis and Q2 prevents obesity and metabolic disorders in rats 53
The Treatment of Cushing's Disease. 52
Prolactin and prostate hypertrophy: a pilot observational, prospective, case-control study in men with prolactinoma 52
A retrospective analysis on biochemical parameters, cardiovascular risk and cardiomyopathy in elderly acromegalic patients 52
The GH-IGF system in amyotrophic lateral sclerosis: correlations between pituitary GH secretion capacity, insulin-like growth factors and clinical features. 52
Accordi di programma "Piattaforme tecnologiche avanzate per la definizione di nuovi biomarkers e bersagli molecolari in vettori nanotecnologici per la diagnosi e la terapia di neoplasie umane" 52
Cardiovascular risk in adult hypopituitaric patients with growth hormone deficiency: is there a role for vitamin D? 52
Adherence to the Mediterranean Diet and Circulating Levels of Sirtuin 4 in Obese Patients: A Novel Association 52
IFN-beta is a highly potent inhibitor of gastroenteropancreatic neuroendocrine tumor cell growth in vitro 51
The severity of growth hormone deficiency correlates with the severity of cardiac impairment in 100 adult patients with hypopituitarism: an observational, case-control study 51
Orbital scintigraphy with [111In-diethylenetriamine pentaacetic acid-D-phe1]-octreotide predicts the clinical response to corticosteroid therapy in patients with Graves' ophthalmopathy. 51
Selenium supplementation modulates apoptotic processes in thyroid follicular cells 51
Cardiopulmonary impairment in young women with polycystic ovary syndrome 51
ACROSTUDY: the Italian experience. 50
Increased prevalence of thyroid autoimmunity and hypothyroidism in patients with glycogen storage disease type I 50
Effects of neridronate treatment in elderly women with osteoporosis 50
Recombinant thyrotropin-induced orbital uptake of [111In-diethylenetriamine-pentacetic acid-D-Phe1]octreotide in a patient with inactive Graves' ophthalmopathy. 50
31. SIX MONTHS OF TREATMENT WITH CABERGOLINE RESTORES SEXUAL POTENCY IN HYPERPROLACTINEMIC MALES. AN OPEN LONGITUDINAL STUDY MONITORING NOCTURNAL PENILE TUMESCENCE. 50
Overexpression of the phosphoprotein enriched in diabetes gene product (Ped/pea-15) in women with polycystic ovary syndrome. 50
The environment and male reproduction: The effect of cadmium exposure on reproductive functions and its implication in fertility 50
Subtle alterations of cardiac performance in children with growth hormone deficiency: results of a two-year prospective, case-control study. 50
Epidemiology, diagnosis, and treatment of male hypogonadotropic hypogonadism. 50
Self-Assessment of Adherence to Medication: A Case Study in Campania Region Community-Dwelling Population 50
CXCR4/CXCL12/CXCR7 axis is functional in neuroendocrine tumors and signals on mTOR 50
Effects of long-term combined treatment with somatostatin analogues and pegvisomant on cardiac structure and performance in acromegaly 50
A New Light on Vitamin D in Obesity: A Novel Association with Trimethylamine-N-Oxide (TMAO) 50
Erratum to: Pasireotide LAR maintains inhibition of GH and IGF-1 in patients with acromegaly for up to 25 months: results from the blinded extension phase of a randomized, double-blind, multicenter, Phase III study. 49
Advances in the treatment of prolactinomas 49
Cabergoline treatment rapidly improves gonadal function in hyperprolactinemic males: a comparison with bromocriptine 49
Glycogen storage disease type Ia (GSDIa) but not Glycogen storage disease type Ib (GSDIb) is associated to an increased risk of metabolic syndrome: possible role of microsomal glucose 6-phosphate accumulation. 48
Flavor identification inversely correlates with Body Mass Index (BMI) 48
The association of fasting insulin concentrations and colonic neoplasms in acromegaly: a colonoscopy-based study in 210 patients 48
Age changes the diagnostic accuracy of mean profile and nadir growth hormone levels after oral glucose in postoperative patients with acromegaly. 48
The natural history of partial growth hormone deficiency in adults: a prospective study on the cardiovascular risk and atherosclerosis. 48
Bone demineralization and vertebral fractures in endogenous cortisol excess: role of disease etiology and gonadal status 48
ETIOPATOGENESI E CLINICA DELLA SINDROME DELL’OVAIO POLICISTICO 48
Sunshine vitamin and thyroid 48
The lullaby of the sun: the role of vitamin D in sleep disturbance. 48
CONVENTIONAL AND NUCLEAR MEDICINE IMAGING IN ECTOPIC CUSHING'S SYNDROME: A SYSTEMATIC REVIEW. 47
First-line octreotide-LAR therapy induces tumour shrinkage and controls hormone excess in patients with acromegaly: results from an open, prospective, multicentre trial. 47
Effects of short-term treatment with orlistat on growth hormone/insulin-like growth factor-I axis in obese post-menopausal women. 47
Pituitary function and morphology in Fabry disease. 47
The role of vitamin D in male fertility: A focus on the testis 47
Human exposure to bisphenol AF and diethylhexylphthalate increases susceptibility to develop differentiated thyroid cancer in patients with thyroid nodules 47
Quality of Life in Patients with Neuroendocrine Neoplasms: The Role of Severity, Clinical Heterogeneity and Resilience 47
L'ESPOSIZIONE AMBIENTALE è UN FATTORE DI RISCHIO MASCHILE? 46
Endocrine dysfunction in patients with Fabry disease 46
Hypertension in acromegaly and in the normal population: prevalence and determinants 46
SOM230, a new somatostatin analogue, is highly effective in the therapy of growth hormone/prolactin-secreting pituitary adenomas. 46
Totale 6.078
Categoria #
all - tutte 144.005
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 144.005


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20203.099 1.279 41 146 73 184 68 44 40 39 223 396 566
2020/20212.590 50 111 298 143 173 532 177 73 268 110 263 392
2021/20226.514 122 40 69 81 125 698 91 206 1.027 327 1.167 2.561
2022/20237.870 1.189 650 207 645 882 788 140 669 1.072 1.078 423 127
2023/20245.245 243 813 701 391 242 413 196 643 58 108 904 533
2024/20251.541 1.541 0 0 0 0 0 0 0 0 0 0 0
Totale 31.320